Login Register
English
0

Cart

$ 0

Bleomycin restricts the glycolysis of lymphatic endothelial cells by inhibiting dimeric PKM2 formation: A novel mechanism for lymphatic malformation treatment(A23210-5.6)

Date:2026-03-03 Views:24